v3.25.4
Revenue Recognition
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
The Company attributes net sales to external customers to the U.S. and to all foreign countries based on the legal entity from which the sale originated. Refer to Note 2. Significant Accounting Policies for further information regarding revenue recognition. The Company had product sales to one customer totaling $64,521 and $59,742, primarily in the U.S. reporting segment representing 11.4% and 10.4% of total net sales during the years ended December 31, 2025 and 2024, respectively. There were no customers representing 10% or more of net sales during the year ended December 31, 2023.
The following table presents the Company’s net sales disaggregated by major products within each segment as follows for the years ended December 31:
202520242023
U.S.
Pain Treatments
$248,237 $234,936 $197,954 
Surgical Solutions180,442 167,706 141,888 
Restorative Therapies73,418 104,167 110,018 
Total U.S. net sales502,097 506,809 449,860 
International
Pain Treatments
30,823 26,353 22,847 
Surgical Solutions23,211 21,549 19,715 
Restorative Therapies11,956 18,569 19,923 
Total International net sales65,990 66,471 62,485 
Total net sales$568,087 $573,280 $512,345